Wildlife experts take urgent action after endangered species nears total collapse: 'Situation was really, really bad'
London-based conservationists are working to restore a vulnerable colony of endangered Darwin's frogs from halfway around the world. Launching an emergency rescue mission in a remote Chilean national park, the conservationists recently rescued 53 adult frogs from a deadly fungus plaguing the colony's native habitat.
In October 2024, researchers from the Zoological Society of London rescued the frogs from Tantauco Park located on the south end of Chiloé Island in southern Chile. That's because the park is home to a deadly fungal infection called chytridiomycosis — or chytrid — fungus.
YaleEnvironment360 explains that chytrid fungus causes a deadly infection that suppresses a frog's immune response. It first attacks the amphibian's skin, an essential barrier in frogs that aids respiration and supports overall health. As the infectious disease progresses, the frog's motor functions fail and it struggles to breathe. Eventually, the frog dies from a heart attack. Darwin's frogs are highly susceptible to the deadly fungus and often die within mere weeks of infection.
According to The Guardian, chytrid fungus has been a problem worldwide for the last three decades, killing off at least 90 species and endangering hundreds more. Experts call it "the most devastating infectious animal disease ever documented."
The Guardian reported that recent conservation monitoring found a 90% decline in the Darwin's frog population at Tantauco Park because of the fungus.
"We realized the situation was really, really bad," Dr. Andrés Valenzuela-Sánchez, a research fellow at the Zoological Society of London, told The Guardian. "We rapidly decided we needed to do something, We needed to do an emergency rescue."
A documentary titled "A Leap of Hope" captures a portion of the team's delicate and difficult rescue. Not only were the frogs on a remote island filled with camouflaging lush vegetation, but the species is incredibly tiny. Darwin's frogs are under 3 centimeters long and weigh just .07 ounces, per London Zoo.
Of the 55 frogs collected from the national park, two were infected with chytrid fungus. The remaining 53 frogs were sent on an 8,000-mile journey by plane, boat, and van to London. There, the frogs settled in a London Zoo habitat that replicated their natural environment with seasonable temperatures, regular rainfall, appropriate lighting, and familiar foliage.
Now settled in the enclosure, 11 rescued males have released 33 young froglets into the habitat, starting a new generation of healthy frogs. Male Darwin's frogs hold young tadpoles in their vocal sacs for brooding, releasing the young frogs out of their mouth once developed.
The conservationists call this new generation a "huge milestone" in their overall mission.
Do you think America does a good job of protecting its natural beauty?
Definitely
Only in some areas
No way
I'm not sure
Click your choice to see results and speak your mind.
"We have the founders, the first adults, and now we have this first generation of offspring born at the zoo," Valenzuela-Sánchez told The Guardian.
Researchers aim to breed the frogs further to help boost their population while exploring treatments and conservation options for chytrid fungus.
The fungus appears to thrive in conditions caused by unstable global temperatures, though studies conflict on why. Some studies found that climate shifts like extreme heat and drought may weaken Darwin's frogs' immune systems, making the species more vulnerable to infection. Others have found that heat could be an antidote for deadly fungus, proposing so-called "frog saunas" — small brick structures covered by miniature greenhouses and placed in the sun — that could help infected frogs clear the infection.
With further research and understanding, conservationists hope to develop treatments for chytrid fungus and eventually return the frogs to their native habitat.
Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 hours ago
- Yahoo
Tampa Police get 300 new lifesaving choking devices from New York-based company
The Brief A company based in New York donated choking rescue devices to the Tampa Police Department. The devices, which are called LifeVac, create a one-way suction to remove lodged food or objects from a choking victim. These devices will be distributed to officers soon. TAMPA, Fla. - A New York-based company donated 300 choking rescue devices to the Tampa Police Department. These devices, called LifeVac, create a one-way suction to remove lodged food or objects from a choking victim. "This is just another tool for us, especially for our youth, to be out there and provide another opportunity to save a life," Tampa Police Chief Lee Bercaw said of the donation. The backstory Last month,a Tampa police officer used back blows to help save a toddler who was choking on a tomato. "That's the reason that we're getting this donation," Bercaw said Friday of the bodycam video. "[LifeVac inventor] Mr. Lih saw that video and said, 'I've got to get that product down here in a generous donation.'" "I knew as a parent, I'd be freaking out. I would be very distressed. So I tried to come up with something really simple. You push it, pull it, and that suction pulls it out," LifeVac President and Creator Arthur Lih said. These devices will be distributed to officers soon. Bercaw told FOX 13 the devices will be placed in patrol cars and will be used in schools and at Police Athletic League youth activities. Dig deeper As shown in LifeVac's online instructional video, the New York-based company said people should first follow choking protocols established by the American Red Cross. That means doing back blows and abdominal thrusts first. And if those actions don't work – or if those actions cannot be completed for whatever reason – then a LifeVac device can come into play. The U.S. Food and Drug Administration (FDA) encourages people to follow established choking rescue protocols by the American Red Cross and the American Heart Association. In an April 2024 update, the FDA said these protocols do not include anti-choking devices: "The safety and effectiveness of anti-choking devices that are being sold over-the-counter have not been established; they are not FDA approved or cleared." Success Stories Just this week, a Georgia police officer used a LifeVac device to save a driver choking on a water bottle cap. Years ago, LifeVac devices were placed in every school in Sarasota County. The Source The information in this story was gathered by FOX 13's Ariel Plasencia.
Yahoo
11 hours ago
- Yahoo
Ransomware group linked to cyberattack on Kettering Health
This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. A ransomware group could be linked to a cyberattack on Kettering Health, the Ohio-based health system said Thursday. The provider said it has reason to believe that the attack, which began in late May and disrupted patient care, was launched by the ransomware group Interlock. The emerging ransomware group has targeted several sectors, including healthcare, according to a report published in November by Cisco Talos, a threat intelligence researcher. Kettering said it has eradicated the tools used by the group, conducted a thorough review of its systems and security protocols, and completed updates and patches. 'We have strong confidence that our network-connected devices are secure, and our connections to our partners are fully protected,' Kettering said in a statement. The attack on Kettering began May 20 when the provider reported a system-wide technology outage and canceled elective inpatient and outpatient procedures. Kettering is still recovering from the cyberattack. The system was able to stop diverting ambulances to other nearby hospitals about a week after the attack started, and core components of its Epic electronic health record were restored early this month, according to updates from Kettering. Cyberattacks have become a significant threat for the healthcare sector. Meanwhile, ransomware, a type of malware that denies users access to their data until a ransom is paid, has been involved in more healthcare data breaches in recent years. These attacks can have major impacts on hospitals, cutting off access to critical technology systems, forcing them to cancel scheduled appointments and pushing providers to send emergency cases to other facilities. Some providers report a rise in patient mortality rates in the wake of ransomware attacks. Recommended Reading Ohio's Kettering Health hit by cyberattack Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12 hours ago
- Yahoo
LEADOPTIK Awarded Key Patents Across Three Continents
Strengthening Global IP Portfolio in Optical Imaging for Minimally Invasive Procedures SAN JOSE, Calif., June 6, 2025 /PRNewswire/ -- LEADOPTIK Inc., a Silicon Valley-based medical imaging company, today announced it has been awarded key patents for its proprietary optical probe across three continents: North America, Europe, and Asia. LEADOPTIK designs and manufactures optical probes for minimally invasive procedures, where two critical factors are essential: high-resolution imaging and a miniaturized form factor. High-resolution imaging enables real-time visualization of tissue microstructure, empowering clinicians with the insight needed to make more informed decisions—whether collecting biopsy samples, resecting tumor margins, or delivering therapies to targeted sites. Equally important is miniaturization. Space is at a premium during minimally invasive procedures, and LEADOPTIK's probe is designed with an exceptionally small footprint to navigate tight anatomical pathways without compromising performance. The company's innovation is powered by cutting-edge metasurface technology—flat optical components created through the fusion of nanofabrication and advanced optical design. Unlike traditional optics, metasurfaces enable ultra-thin, high-performance imaging systems that are ideal for integration into medical devices. These three newly granted patents underscore LEADOPTIK's leadership in medical imaging: U.S. Patent (#US11953698B1): Covers a novel device-level metasurface design that significantly extends imaging depth without sacrificing resolution. The patent was granted with 100% of its original claims—a testament to the novelty of LEADOPTIK's approach. European and Japanese Patents (PCT065237 & PCT029301): Protect both the current probe assembly method and alternative configurations that support expanded clinical applications. "Building robust and scalable medical devices is non-negotiable," said Reza Khorasaninejad, CEO and Co-founder of LEADOPTIK. "Our team has not only invented new optical designs but also developed novel methods of integrating them with semiconductor-grade manufacturing processes. These patents reflect our commitment to making next-generation imaging accessible, reliable, and globally protected." "Our intellectual property is the foundation of LEADOPTIK's competitive edge," said Dr. Jiang You, Co-Founder and VP of Medical Imaging. "These patents not only protect our unique optical architecture but also validate the deep technical innovation required to miniaturize high-resolution imaging. It's a major milestone that strengthens our ability to scale globally and expand into new clinical applications." About LEADOPTIK LEADOPTIK is a Silicon Valley-based company pioneering AI-enhanced real-time optical imaging at the point of biopsy. By integrating high-resolution microstructural visualization with emerging analytics, the LIA system bridges the gap between diagnosis, and therapy, supporting more precise and informed decision-making in interventional pulmonology and beyond. For more information, visit Media Contact:hello@ View original content: SOURCE LEADOPTIK Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data